No black box warning on record for Atropine Sulfate

As of the latest FDA labeling reviewed, Atropine Sulfate (ATROPINE SULFATE) does not carry a black box warning. Standard warnings and precautions still apply — see the full Atropine Sulfate medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Tachycardia When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand. 5.2 Acute Glaucoma Atropine may precipitate acute glaucoma. 5.3 Pyloric Obstruction Atropine ma

No black box warning on record for Atropine Sulfate

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS 5.1 Tachycardia When the recurrent use of atropine is essential in patients with coronary artery disease, the total dose should be restricted to 2 to 3 mg (maximum 0.03 to 0.04 mg/kg) to avoid the detrimental effects of atropine-induced tachycardia on myocardial oxygen demand. 5.2 Acute Glaucoma Atropine may precipitate acute glaucoma. 5.3 Pyloric Obstruction Atropine ma

Atropine Sulfate Black Box Warning

No black box warning on record for Atropine Sulfate

Other warnings & precautions

Atropine Sulfate Black Box Warning

No black box warning on record for Atropine Sulfate

Other warnings & precautions